Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.

about

Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.

Item

http://www.wikidata.org/entity/Q40275032

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cryptococcal osteomyelitis and ...... s lymphoma treated with PEP-C.

@en

type

Item

label

Cryptococcal osteomyelitis and ...... s lymphoma treated with PEP-C.

@en

prefLabel

Cryptococcal osteomyelitis and ...... s lymphoma treated with PEP-C.

@en

P1476

Cryptococcal osteomyelitis and ...... s lymphoma treated with PEP-C.

@en

P2093

Alice C Fan

http://www.w3.org/2001/XMLSchema#string

Christina A To

http://www.w3.org/2001/XMLSchema#string

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

James Scott McClellan

http://www.w3.org/2001/XMLSchema#string

Janice M Y Brown

http://www.w3.org/2001/XMLSchema#string

Nancy J Fischbein

http://www.w3.org/2001/XMLSchema#string

Robert W Hsieh

http://www.w3.org/2001/XMLSchema#string

Walter Howard

http://www.w3.org/2001/XMLSchema#string

P2860

Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.

Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations

Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity.

Fluconazole treatment of cryptococcal rib osteomyelitis in an HIV-negative man. A case report and review of the literature.

Cryptococcal meningitis in non-HIV-infected patients.

Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients.

Cryptococcal osteomyelitis in the ribs

P31

scholarly article

case report

P356

10.1136/BCR.08.2011.4578

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22962380

http://www.w3.org/2001/XMLSchema#string

P921

meningitis

P932

3448757

http://www.w3.org/2001/XMLSchema#string